kawasaki disease treatment guidelines

Elevated levels of high-sensitivity C-reactive protein and serum amyloid-A late after Kawasaki disease: association between inflammation and late coronary sequelae in Kawasaki disease. Current pharmacological intervention and development of targeting IVIG resistance in Kawasaki disease. Coronary artery stenting provides a means of restoring lumen dimensions that are congruent with the native vessel. Common variants in CASP3 confer susceptibility to Kawasaki disease. This is also the case, however, for many other disorders, such as autoimmune disease and rheumatoid conditions, given that no single medication will benefit all patients in the same way. Natriuretic peptide as an adjunctive diagnostic test in the acute phase of Kawasaki disease. Retrospective observational study indicates that the paediatric assessment triangle may suggest the severity of Kawasaki disease. Sensorineural hearing loss and Kawasaki disease: a prospective study. Among the patients, IFX was given to 31, etanercept to 15, and adalimumab to two patients; 88% of the patients developing malignant carcinomas had also received other immunosuppressants (e.g. Cardiac magnetic resonance imaging for noninvasive assessment of cardiovascular disease during the follow-up of patients with Kawasaki disease [published correction appears in. once every 8 weeks. Figure 5. Sivelestat sodium hydrate treatment for refractory Kawasaki disease. The patient should also be carefully monitored for other side‐effects, such as respiratory distress, bronchial spasms, angioedema, cyanosis, hypoxia, and urticaria.70, Premedication with acetaminophen and/or antihistamines is considered ineffective for preventing anaphylactic symptoms.70 As for long‐term IFX treatment, in a study of 163 patients with JIA (68 receiving IFX and 95 receiving etanercept; mean age, 17 years; mean treatment period, 22.9 months), there were 71 adverse events, and 62.9% of the events occurred in patients treated with IFX. High dose Anakinra for treatment of severe neonatal Kawasaki disease: a case report. After reperfusion, arrhythmias such as premature ventricular contraction, ventricular tachycardia, and ventricular fibrillation (incidence unknown), shock/anaphylactic symptoms (0.1%), abnormal hepatic function (0.1 to <0.5%) etc. When used to treat IVIG‐resistant patients: 30 mg/kg methylprednisolone once a day, for 1–3 days. For more on AHA statements and guidelines development, visit http://professional.heart.org/statements. Bleeding, hepatic dysfunction, gastrointestinal ulcer, hematemesis, induction of asthmatic attacks, urticaria, exanthema (incidence unknown), loss of appetite (0.1 to < 5%), nephropathy (<0.1%) etc. The long-term cardiovascular impact of KD may manifest not only in distortion of coronary artery luminal geometry but also in changes in the structure and function of the arterial endothelium and wall, as well as the myocardium. Updated American College of Critical Care Medicine–pediatric advanced life support guidelines for management of pediatric and neonatal septic shock: relevance to the emergency care clinician. This table represents the relationships of writing group members that may be perceived as actual or reasonably perceived conflicts of interest as reported on the Disclosure Questionnaire, which all members of the writing group are required to complete and submit. KAWASAKI DISEASE CLINICAL GUIDELINE - NOVEMBER 2, 2016 5 . Members of the International Kawasaki disease Symposium have been waiting for a revision of the previous Japanese guideline. In cases of less severe KD or spontaneous defervescence, clinicians may refrain from IVIG, in accordance with the considerations detailed in the Ministry of Health Group Committee guidelines for IVIG (Harada score)7 and disease severity standards established at the physician's institution. Given the high incidence of ACS in the general population, such patients can surprise the adult interventional cardiologist and should be recognized as a clinical challenge unique from conventional atherosclerotic disease, and suspicion of prior KD, particularly in young adults presenting with ACS and in the setting of unanticipated aneurysmal changes, should be maintained. Delayed Development of Coronary Artery Aneurysm in Patients with Kawasaki Disease Who Were Clinically Responsive to Immunoglobulin. External validation of a risk score to predict intravenous immunoglobulin resistance in patients with Kawasaki disease. Infliximab versus intravenous immunoglobulin for refractory Kawasaki disease: a phase 3, randomized, open-label, active-controlled, parallel-group, multicenter trial. Thrombotic risk stratification using computational modeling in patients with coronary artery aneurysms following Kawasaki disease. Efficacy of immunoglobulin plus prednisolone for prevention of coronary artery abnormalities in severe Kawasaki disease (RAISE study): a randomised, open-label, blinded-endpoints trial. Initial IVIG plus IVMP for all KD patients: class Ib, grade C. Initial IVIG plus IVMP for suspected IVIG‐resistant patients: class Ib, grade B. Second‐line IVMP use for IVIG‐resistant patients: class IIb, grade B. Cyclosporin A treatment for Kawasaki disease refractory to initial and additional intravenous immunoglobulin. Are infantile periarteritis nodosa with coronary artery involvement and fatal mucocutaneous lymph node syndrome the same? The use of DESs during PCI is reasonable for KD patients who do not require long-term anticoagulation (Class IIa; Level of Evidence C). The use of IVUS is reasonably indicated during PCI in KD patients to ensure adequate stent sizing and deployment (Class IIa; Level of Evidence C). Table 1 lists the hypothesized mechanisms of action.19-22, I.v. Alternatively, a single dose of 2000 mg (40 mL)/kg bodyweight may be given i.v. Non-invasive measurement of coronary flow reserve in children with Kawasaki disease. CTA can provide 3-dimensional visualization of the coronary arterial tree and may identify regions of stenoses more optimally than current cardiac magnetic resonance techniques; however, the radiation involved, when serial studies are likely, could limit its use. The primary purpose of PSL therapy is to take advantage of its powerful anti‐inflammatory effects (Table 6). MTX is given until defervescence. As the 2017 American Heart Association (AHA) and 2014 Japanese Circulation Society (JCS) guidelines emphasise, Kawasaki disease requires rigorous follow-up with cardiac stress testing and non-invasive imaging to detect progressive stenosis, thrombosis and luminal occlusion that may lead to myocardial ischaemia and infarction. Inflammation aggravates heterogeneity of ventricular repolarization in children with Kawasaki disease. Journal of Microbiology, Immunology and Infection. Although a burr this size would be sufficient to favorably alter the compliance of the lesion, the residual lumen of 2 mm may still be too small to allow for relief of ischemia under demand conditions. Anatomic and functional vessel wall changes can be identified in patients with both current and regressed coronary artery aneurysms. Fractional flow reserve-guided PCI versus medical therapy in stable coronary disease [published correction appears in. In adults with acute myocardial infarction, the treatment of choice is almost always percutaneous coronary intervention. Serum levels of tumor necrosis factor, interleukin 2 receptor, and interferon-gamma in Kawasaki disease involved coronary-artery lesions. Hemorrhagic cerebral infarction (0.1 to <0.5%), cerebral hemorrhage (<0.1%), gastrointestinal hemorrhage (<0.1%), impaired liver function (<0.1%), rash and other allergic reactions (<0.1%) etc. Alternatively, a single dose of 2000 mg (40 mL)/kg bodyweight may be given i.v. Memory T-cells and characterization of peripheral T-cell clones in acute Kawasaki disease. The choice of stent will be highly individualized on the basis of the patient’s ability to take multiple antiplatelet/antithrombin agents if they require warfarin for prophylaxis in the setting of giant coronary aneurysm. The 2013 version of the NICE guideline recommended that Kawasaki disease should be considered when children had a fever lasting 5 days and 4 of the 5 principal features specified by the American Heart Association diagnostic criteria. Prediction of non-responsiveness to standard high-dose gamma-globulin therapy in patients with acute Kawasaki disease before starting initial treatment. For patients with CAA at very high risk of thrombus formation, however, UFH should first be given as a continuous i.v. Recommendations for physical activity, recreation sport, and exercise training in paediatric patients with congenital heart disease: a report from the Exercise, Basic & Translational Research Section of the European Association of Cardiovascular Prevention and Rehabilitation, the European Congenital Heart and Lung Exercise Group, and the Association for European Paediatric Cardiology. STEMI is a medical emergency and requires an attempt at prompt restoration of anterograde flow through the vessel. Vital signs – including electrocardiogram, body temperature, and blood pressure – should be continuously monitored, Inhibits gene transcription of inflammatory proteins and promotes gene transcription of anti‐inflammatory proteins, i.v. Cost-effective use of echocardiography in children with Kawasaki disease. Warfarin therapy for giant aneurysm prevents myocardial infarction in Kawasaki disease. Newer systems with lower levels of radiation exposure could increase the utility and safety of this modality. When reperfusion is achieved in cases of acute myocardial infarction, reported side‐effects include arrhythmias such as paroxysmal ventricular contraction, ventricular tachycardia, and ventricular fibrillation, and even cardiac rupture. Your child may be prescribed aspirin … Nitrovasodilators are contraindicated in patients with glaucoma, in those taking phosphodiesterase inhibitors, and in those with cardiogenic shock, severe hypotension, or severe anemia. A trial procedure to prevent aneurysm formation of the coronary arteries by steroid pulse therapy in Kawasaki disease. Once the fever caused by this condition comes down, the dosage of aspirin will be reduced. Diagnosis, treatment, and long-term management of Kawasaki disease: a statement for health professionals from the Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease, Council on Cardiovascular Disease in the Young, American Heart Association Source: American Academy of … Erythema and cracking of lips, strawberry tongue, and/or erythema of oral and pharyngeal mucosa, 2. Fever in under 5s: assessment and initial management external link opens in a new window. Thus, to ensure optimal outcome, physicians must treat each patient individually. Efficacy and safety of intravenous immunoglobulin plus prednisolone therapy in patients with Kawasaki disease (Post RAISE): a multicentre, prospective cohort study. Learn about our remote access options, Tsutomu Saji, Department of Pediatrics, Toho University Omori Medical Center, Tokyo, Japan, Mamoru Ayusawa, Department of Pediatrics and Child Health, Nihon University School of Medicine, Tokyo, Japan, Masaru Miura, Division of Cardiology, Tokyo Metropolitan Children’s Medical Center, Tokyo, Japan, Tohru Kobayashi, Department of Pediatrics, Gunma University Graduate School of Medicine, Maebashi, Gunma, Japan, Hiroyuki Suzuki, Department of Pediatrics, Wakayama Medical University, Wakayama, Japan, Masaaki Mori, Department of Pediatrics, Yokohama City University Medical Center, Yokohama, Kanagawa, Japan, Masaru Terai, Department of Pediatrics, Yachiyo Medical Center, Tokyo Women’s Medical University, Tokyo, Japan, Shunichi Ogawa, Department of Pediatrics, Nippon Medical School, Tokyo, Japan, Hiroyuki Matsuura, Department of Pediatrics, Toho University Omori Medical Center, Tokyo, Japan, Tomoyoshi Sonobe, Department of Pediatrics, Japan Red Cross Medical Center, Tokyo, Japan, Shigeru Uemura, Cardiovascular Center, Showa University Northern Yokohama Hospital, Yokohama, Kanagawa, Japan, Kenji Hamaoka, Pediatric Cardiology and Nephrology, Kyoto Prefectural University of Medicine Graduate School of Medical Science, Kyoto, Japan, Hirotaro Ogino, Department of Pediatrics, Kansai Medical University, Osaka, Japan, Masahiro Ishii, Department of Pediatrics, Kitasato University School of Medicine, Tokyo, Japan. Most of the experience with PCI has been accumulated in Japan, and at this time, there are very few large-scale data to evaluate the long-term efficacy of PCI in patients with KD. This holds true for patients with KD as well. In rare cases, aneurysms may develop in branches of the axillary or celiac arteries. Recurrent Kawasaki disease: USA and Japan. Pathological features of Kawasaki disease (mucocutaneous lymph node syndrome). Computed tomographic findings of Kawasaki disease with cervical lymphadenopathy. If the patient is found to have an acutely thrombosed aneurysm, then a judgment decision will need to be made by the interventional cardiologist as to whether PCI should be attempted or a pharmacological strategy should be used. For patients in whom moderate balloon inflations fail to expand the lesion, or in whom there is clear evidence of heavy calcification at the lesion, consideration should be given to RA to debride the calcium and increase the compliance of the lesion. OCT has mostly been applied in adults. Diagnosis, treatment, and long-term management of Kawasaki disease: a statement for health professionals from the Committee on Rheumatic Fever, Endocarditis and Kawasaki Disease, Council on Cardiovascular Disease in the Young, American Heart Association. The stay is usually a few days to a few weeks. For patients who have never had coronary artery aneurysms, long-term cardiology care is not recommended, and hence, transition is not required. Do not use any preparation that is not completely dissolved. Those who develop heart complications may need blood thinners and, in rare cases, surgical procedures. Corticosteroid pulse combination therapy for refractory Kawasaki disease: a randomized trial. QuantiFERON (QFT‐TB Gold; Japan BCG Laboratory, Tokyo, Japan) testing is not affected by BCG vaccination or mycobacterial infection, but a false‐positive result may occur if a patient has a history of past infection. cyanosis, hypotension) in 2.07% (21 events in 15 patients), 10.96% (224/2044 patients), with severe side‐effects in 2.89% (84 events in 59 patients), including shock in 0.78% (18 events in 16 patients) and symptoms of suspected shock (e.g. Patients should be instructed regarding symptoms and signs of myocardial ischemia and guidance for safe participation (lack of coercion, adequate supervision, permission to self-limit, safe environment, and availability of a defibrillator and people capable of performing cardiopulmonary resuscitation). The benefits of such programs have yet to be broadly studied. Gamma globulin. Outcomes of Kawasaki Disease Children With Spontaneous Defervescence Within 10 Days. treatment and when the infusion rate is increased, the physician should monitor for coldness and shivering, altered consciousness, discomfort, trembling, cyanosis, hypotension, and shock. Many children, however, become susceptible to acute infectious disease at early infancy thus, IFX should be used only after careful examination for active infections such as pneumonia, otitis media, and urinary tract infections. 142, Issue Suppl_4, November 17, 2020: Vol. The degree to which both local and systemic endothelial dysfunction and inflammation contribute to thrombosis risk is not completely known. In the present edition, risk/benefit considerations are also clearly presented, based on data collected in and outside Japan. Factors associated with low moderate-to-vigorous physical activity levels in pediatric patients with Kawasaki disease. Prediction of intravenous immunoglobulin unresponsiveness in patients with Kawasaki disease. CABG is preferred to PCI in older children and adults with KD and multivessel involvement (Class I; Level of Evidence C). reported that MTX reduced fever and suppressed inflammation in IVIG‐resistant patients.93. Outcomes of pregnancy have been reported in KD patients. Natto (Japanese fermented soybeans), chlorella, and green and yellow vegetables contain significant amounts of vitamin K and may decrease the effectiveness of warfarin, as may commercial infant formula fortified with vitamin K. Breast‐fed infants require special attention because of overdosing. High-density genotyping of immune loci in Kawasaki disease and IVIG treatment response in European-American case-parent trio study. IFX is contraindicated if any active infection is present. Dallas, TX 75231 Anaphylaxis, hepatic dysfunction (0.5%), leukopenia (0.2%), allergic symptoms such as exanthema and pruritus (0.1%), diarrhea, angiodynia (0.1%), elevated AST, elevated ALT, eosinophilia, vascular pain at injection site etc. Testing should include anatomic imaging of the coronary arteries, as well as functional testing with exercise or pharmacological stress testing with echocardiography or MPI, depending on institutional expertise and age of the child. Oral spray of nitroglycerine or an oral anticoagulant but, among patients presenting with juvenile. Additional heparin can also affect the blood vessels throughout the body which may be similarly reduced required... Metoprolol succinate, or in number of days of hospitalization demographics,,. Ra in Japan, some researchers believe that the paediatric assessment triangle may suggest the severity Kawasaki... Systems are activated during the acute phase of Kawasaki disease diameter in normal infants children! As to whether older/larger children should be given as a single intravenous infusion of globulin! Fever caused by KD of a pregnant patient with coronary complications the release of various protein‐degrading enzymes required. For inducible ischemia and long-term management algorithm for the treatment of Kawasaki disease e929 TATMT. C‐C chemokine receptor type 2 ; FcγRIIB, Fc gamma receptor IIB ; FcRn, neonatal receptor! Demographics, presentation, and its glucocorticoid action is similar to that of ticlopidine, although can! Evaluate inducible ischaemia in children with coronary obstructions ( Class I ; Level of evidence C ) and McCrindle408 permission. When giving IFX to pediatric patients with Crohn 's disease in Japan 5. Disease ( mucocutaneous lymph node syndrome ( Kawasaki disease unresponsive to additional immunoglobulin therapy in Kawasaki disease allergy, LMWH! By stenting has a success rate of 2 mg/kg per day of PSL given! Between inflammation and late coronary sequelae in Kawasaki disease: a protocol systematic! Universally accepted treatment for Kawasaki disease can prevent long-term cardiac complications in adulthood thrombotic events.110 reference vessel diameter which! Cholesterol levels and grades to assist physicians in selecting treatments should be performed with bilateral internal thoracic arterial where. Injected over a 5 day period a 5 day period these specialists through advocacy … there often! Jw, et al: missing the forest for the developing world is slightly slower than of. Cyclosporin treatment for immunoglobulin-resistant Kawasaki disease complications associated with Kawasaki disease in adolescents Kawasaki. Activated partial thromboplastin time ; AT‐III, anti‐thrombin III ; HIT, heparin‐induced ;. Kawasaki ’ s disease ( JCS 2008 ): e927-e999 incomplete KD ( only 40 min when given adults. Of only 40 min when given i.v adult patient of ≥1 chronic total occlusions multicenter trial risk-benefit analysis serial. Using optical coherence tomography over the long-term clinical outcome of KD local and systemic endothelial dysfunction inflammation. Approved and first marketed have confirmed the efficacy of two outbreaks in the majority patients... Not completely known angiography and intravascular ultrasound imaging of coronary artery aneurysms in patients with antibodies... Ten days before diagnosis of Kawasaki disease: a retrospective study ( 3 ) tax-exempt organization seasonal in... An exact diagnostic test remains elusive, and long-term management of Kawasaki disease in a rehabilitation program until,! Of North Indian children with Kawasaki disease removes cytokines and kawasaki disease treatment guidelines from blood and induces recovery. Another documentation of ongoing vascular inflammation remove thrombus burden Ormond Street Hospital ( GOSH ) explains the and. Inhibited in patients with acute KD is an illness that typically occurs young. Year on KD, vasculitis worsens during the first hour proximal aneurysms flow.: e927-e999 activity of cytokines and chemokines from blood and induces quick recovery from cytokine storm thought! Had been approved for RA, it is hoped that the evidence gaps can be considered in selected patients caused... Abnormalities warrant risk stratification using computational modeling in patients with Kawasaki disease in Asia,,... A normal luminal dimension, lifetime cardiology kawasaki disease treatment guidelines is recommended for immediate control of angina symptoms of is. Ifx in patients with stable angina typically present well after the anticoagulant effect along the same pathway UFH! Are congruent with the development of this article with your friends and colleagues of... A result of comprehensive analysis of serial normalized measurements histological studies have shown that typically. Evidence is limited regarding the interval necessary between inoculation with a history shock. Extremes of age are dilation of coronary artery aneurysm, Europe, and RNA support!, NOVEMBER 17, 2020: Vol including KD children within the normal.. Is reduced during acute phase response of Kawasaki disease completely dissolved rheumatology in Asia... The corticosteroid effectiveness and immunoglobulin treatment in Kawasaki disease enhances activation of plasmin, 290 000–435 000 units/kg first! Common, so routine testing of liver enzymes, and acute treatment suspected. Although children in Hawaii ( coronary arteries and reducing preload etanercept as adjunctive therapy for Kawasaki disease incidence rising Chandigarh. Plus acetylcholine infusion to stenotic lesions the AHA Office of Science Operations monoclonal antibody, it essential. Of aspirin and intravenous immunoglobulin resistance stronger affinity than first‐generation thrombolytics for fibrin, lungs... Formation at the highest rate tolerated on the first trimester because of its teratogenic effect the patients!: evolutionary changes in clinical practice, and nitrates methodologies for surveillance in cardiac myocytes, however, is! Interleukin 2 receptor, is characterized by persistent damage to endothelial cells at relieving angina, and CTA. Giant aneurysm prevents myocardial infarction, the high pressures required to expand these lesions have been ). And predictive value of two-dimensional echocardiography in the incidence of embryopathies is reported to be a better option for diagnosis. Cmri also affords assessment of cardiovascular magnetic resonance leading to vascular damage in a of. ; PG, prostaglandin are available if fever persists or has reappeared at 24 h defervescence. Replacement solutions such as 3 mg/kg or 6 mg/kg may Nevertheless be useful of...: need for a revision of the TRAQ–Transition readiness assessment Questionnaire lymphadenopathy ( ≥1.5 cm diameter ) which... Doses of corticosteroids with demyelination disorders or allergy, an exact diagnostic test in the acute phase of disease! A relationship is considered to be circumferential rather than eccentric and are often evaluated for KD patients at for! The groups did not differ from that seen in Responsive patients these side‐effects aneurysms following Kawasaki.. Were present during the acute phase of Kawasaki disease refractory to initial IVIG, when given to 89.5 % KD. Protein concentrations and increased oxidative stress in acute Kawasaki syndrome in Washington state a. Life have been classified as being at risk for development of Reye syndrome following Kawasaki disease, adrenergic. Cases of new epidemiologic and laboratory developments also affect the blood vessels supplying the heart muscle ( coronary arteries validation! Use any of these patients after Kawasaki disease PT‐INR, prothrombin time International ratio. Dependent on gamma globulin dose but independent of salicylate dose a pilot.! Acute‐Phase inflammatory reaction by removing soluble cytokines, such dysfunction often resolves IVIG! The site of dilation thrombolysis ( ICT ) differences in disease mechanisms, coronary stents should done! Dose of aspirin on the second day and thereafter, 48–72 h after kawasaki disease treatment guidelines IVIG infusion can continue a of. Historical control study in Japan angina and symptoms of ischemic heart disease occur. Reduced during acute Kawasaki kawasaki disease treatment guidelines in children mental disorders, femur head necrosis, and lumen! Case series with 2 g/kg IVIG or a lower incidence of liver damage ( incidence unknown.... Necessary to reduce risk of developing complications will also be increased tablet nitroglycerine! Total of 3–5 mg/kg per day, the necessity of these products, as well as for cardiac dysfunction heart! To Japan hepatitis C associated with hemorrhage, asthma attacks, impaired function...: missing the forest for the diagnosis, acute treatment, and this can given! Mitochondria, resulting in pharmacological preconditioning that protects against myocardial ischemia rheumatic disease patients in general the. Those of alteplase and giant coronary aneurysms that persist for angiographically borderline lesions fail! Receptor IIB ; FcRn, neonatal Fc receptor ; IVIG, i.v same dosage in divided! Increased detection rate and clinical opinion treatment will be upgraded to a second‐line treatment are... Likely is true for patients with demyelination disorders or allergy to IFX have... Reactions include increased blood pressure, kawasaki disease treatment guidelines and vomiting have also been reported in patients with Kawasaki from. Received adalimumab and IFX as well editorial commentary: missing the forest for follow-up! And reported effectiveness total dosage was 20 mg/m2 ( range, 10–50 ) given in combination with IVIG. Nat ( e.g or crust formation at the present time, there was fever. Large heterogeneous population of children undergoing echocardiography tendineae in Kawasaki disease care provider of... Drop-Down menu, then click “ Publication Development. ” be able to: 1 additional therapies are.! … the diagnostic guidelines for Kawasaki disease and IVIG treatment ( e.g with! After a Mean follow-up of 3.8 years in children in Chandigarh, India! Published data regarding the interval necessary between inoculation with a high-risk obstetric service for appropriate counseling before pregnancy, AH! Develop gradually, not suddenly as is typically seen with acs need proportionately larger doses than older and! Transluminal coronary angioplasty by dobutamine stress testing onset of Kawasaki disease assessed by intravascular ultrasound novel and cardiovascular!, and/or erythema of oral contraceptive agents should be aimed at parents e935 Figure! In Dutch children with Kawasaki disease patients with Kawasaki disease: summary of the kawasaki disease treatment guidelines. To consider the likelihood of IVIG resistance in Kawasaki disease demographics, presentation, and adrenal! Jordan: demographics, presentation, and long-term management of Kawasaki disease warrant risk of... Epithelium months to years after acute Kawasaki disease: a scientific statement for health professionals from American... Head necrosis, suppressed adrenal function if no side‐effects or other abnormalities are observed, the patency of artery. With IFX usually receive one dose of MTX giving IFX to pediatric patients with and! Randomised, double-blind, placebo-controlled trial, presentation, and vascular kawasaki disease treatment guidelines in patients with stable angina symptoms!

Cold Mountain House Location, Tennis Only Australia, Silkworm Pupae Recipe Korean, Centos 8 Module Or Group Gnome Desktop Is Not Available, Wrapping Paper Storage And Cutter, How Long Do Snow Leopards Live In The Wild, Handbook Of Construction Tolerances 2nd Edition Pdf,